AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32811623 — intervention group
Group type: EXPERIMENTAL
Intervention: XR-NTX only
Number of subjects: 135
Study 32811623 — intervention group
Group type: EXPERIMENTAL
Intervention: XR-NTX + PN
Number of subjects: 135
Study 32811623 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Treatment-as-Usual (ETAU)
Number of subjects: 135
Study 33612554 — intervention group
Group type: EXPERIMENTAL
Intervention: 2nd-generation drug-eluting stents (n=59)
Number of subjects: 112
Study 33612554 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stents (n=53)
Number of subjects: 112
Study 33612554 — intervention group
Group type: EXPERIMENTAL
Intervention: Both BMS and 2nd-generation DES
Number of subjects: 112
Study 33612554 — intervention group
Group type: COMPARATOR
Intervention: Target vessels with BMS
Number of subjects: 112
Study 34106454 — intervention group
Group type: EXPERIMENTAL
Intervention: ipilimumab-nivolumab
Number of subjects: 0
Study 34106454 — intervention group
Group type: EXPERIMENTAL
Intervention: platinum chemotherapy and durvalumab
Number of subjects: 0
Study 34106454 — intervention group
Group type: COMPARATOR
Intervention: nivolumab
Number of subjects: 0
Study 34106454 — intervention group
Group type: COMPARATOR
Intervention: tremelimumab
Number of subjects: 0
Study 34106454 — intervention group
Group type: COMPARATOR
Intervention: pembrolizumab
Number of subjects: 0
Study 34106454 — intervention group
Group type: COMPARATOR
Intervention: chemo-immunotherapy
Number of subjects: 0
Study 32346001 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy (60% of patients)
Number of subjects: 90
Study 32346001 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up measurement
Number of subjects: 90
Study 34822104 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax (400-800 mg) administered with R-CHOP for eight 21-day cycles (cycle 1: days 4-10; cycles 2-8: days 1-10)
Number of subjects: 216
Study 34822104 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax (400-800 mg)
Number of subjects: 216
Study 34822104 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax (800 mg) with R-CHOP
Number of subjects: 216
Study 34822104 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP (historical control from GOYA study)
Number of subjects: 216
Study 35363510 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib (MEK inhibitor), administered twice daily for 28-day cycles until disease progression or intolerable toxicity.
Number of subjects: 20
Study 35363510 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib (MEK inhibitor)
Number of subjects: 20
Study 35409821 — intervention group
Group type: EXPERIMENTAL
Intervention: One-day workshop for managers
Number of subjects: 70
Study 35409821 — intervention group
Group type: COMPARATOR
Intervention: Waiting control group
Number of subjects: 70
Study 34809672 — intervention group
Group type: EXPERIMENTAL
Intervention: Active electronic alert for sepsis
Number of subjects: 45
Study 34809672 — intervention group
Group type: COMPARATOR
Intervention: Masked alert (control)
Number of subjects: 45
Study 32611826 — intervention group
Group type: EXPERIMENTAL
Intervention: Persian version of State-Trait Anxiety Inventory (STAI-Y)
Number of subjects: 492
Study 35777775 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone lung cancer risk assessment with general practitioner endorsement and reminders
Number of subjects: 44943
Study 35777775 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 44943
Study 32565102 — intervention group
Group type: EXPERIMENTAL
Intervention: Exteroceptive and proprioceptive sensory stimulations for 6 weeks
Number of subjects: 60
Study 34247027 — intervention group
Group type: EXPERIMENTAL
Intervention: Melissa essential oil (inhaled 2 drops for 10 min with 90-min intervals)
Number of subjects: 72
Study 34247027 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sunflower oil inhaled 2 drops for 10 min with 90-min intervals)
Number of subjects: 72
Study 33242775 — intervention group
Group type: EXPERIMENTAL
Intervention: MINDSET plus Usual Care (n = 46)
Number of subjects: 94
Study 33242775 — intervention group
Group type: COMPARATOR
Intervention: Usual Care Only (n = 48)
Number of subjects: 94
Study 34619500 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated CBT and acupressure (CBTAcup)
Number of subjects: 40
Study 34619500 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 40
Study 34619500 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control (WL)
Number of subjects: 40
Study 34763045 — intervention group
Group type: EXPERIMENTAL
Intervention: Bufei Huoxue (BFHX)
Number of subjects: 131
Study 34763045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 36089974 — intervention group
Group type: EXPERIMENTAL
Intervention: Martial arts routines
Number of subjects: 0
Study 36089974 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional treatment)
Number of subjects: 0
Study 33245118 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives for dietary self-monitoring and weekly weight loss
Number of subjects: 93
Study 33245118 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (Cohort 1)
Number of subjects: 93
Study 33245118 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-calorie diet (Cohort 2)
Number of subjects: 93
Study 33245118 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (Cohort 3)
Number of subjects: 93
Study 34871550 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib, daratumumab, and dexamethasone (KdD)
Number of subjects: 466
Study 34871550 — intervention group
Group type: COMPARATOR
Intervention: Carfilzomib and dexamethasone (Kd)
Number of subjects: 466
Study 33879352 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TENS + Active JM
Number of subjects: 144
Study 33879352 — intervention group
Group type: COMPARATOR
Intervention: Active TENS + Placebo JM
Number of subjects: 144
Study 33879352 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS + Active JM
Number of subjects: 144
Study 33879352 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS + Placebo JM
Number of subjects: 144
Study 34456322 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial facial massage
Number of subjects: 151
Study 34456322 — intervention group
Group type: EXPERIMENTAL
Intervention: Various massage techniques for facial muscle relaxation
Number of subjects: 151
Study 33275467 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise for 60 minutes, 2 days a week, for 3 months
Number of subjects: 39
Study 33275467 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 39
Study 32033582 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (10 μg/kg or 15 μg/kg)
Number of subjects: 85
Study 32033582 — intervention group
Group type: COMPARATOR
Intervention: Naloxone (titrated doses)
Number of subjects: 85
Study 34705168 — intervention group
Group type: EXPERIMENTAL
Intervention: FiO2 of 0.8 (Group 1)
Number of subjects: 30
Study 34705168 — intervention group
Group type: COMPARATOR
Intervention: FiO2 of 0.6 (Group 2)
Number of subjects: 30
Study 33944597 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine A (2 mL, 1 mL/nostril)
Number of subjects: 90
Study 33944597 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine B (2 mL, 1 mL/nostril)
Number of subjects: 90
Study 33944597 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.9% NaCl) solution (2 mL)
Number of subjects: 90
Study 32438828 — intervention group
Group type: EXPERIMENTAL
Intervention: MSTEP© (tailored exercise programme)
Number of subjects: 137
Study 32438828 — intervention group
Group type: COMPARATOR
Intervention: Guideline (general exercise guidelines)
Number of subjects: 137
Study 32438828 — intervention group
Group type: EXPERIMENTAL
Intervention: MSTEP©
Number of subjects: 137
Study 32438828 — intervention group
Group type: COMPARATOR
Intervention: Guideline
Number of subjects: 137
Study 35086692 — intervention group
Group type: EXPERIMENTAL
Intervention: KVD900 600 mg tablet under fasted conditions
Number of subjects: 98
Study 35086692 — intervention group
Group type: EXPERIMENTAL
Intervention: KVD900 600 mg tablet
Number of subjects: 98
Study 35086692 — intervention group
Group type: EXPERIMENTAL
Intervention: KVD900 600 mg dose
Number of subjects: 98
Study 35086692 — intervention group
Group type: COMPARATOR
Intervention: KVD900 (various doses)
Number of subjects: 98
Study 33784967 — intervention group
Group type: EXPERIMENTAL
Intervention: GP research networks as a recruitment strategy
Number of subjects: 130
Study 33784967 — intervention group
Group type: COMPARATOR
Intervention: Cold calls as a recruitment strategy
Number of subjects: 130
Study 32865465 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM applied with 30 J per area (PBM1)
Number of subjects: 15
Study 32865465 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM applied with 120 J per area (PBM2)
Number of subjects: 15
Study 32865465 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM applied with 180 J per area (PBM3)
Number of subjects: 15
Study 32865465 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 15
Study 32865465 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 15
Study 35461287 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard measles vaccine
Number of subjects: 5400
Study 35461287 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 5400
Study 32107938 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-lowering agents (high-intensity statins)
Number of subjects: 0
Study 32107938 — intervention group
Group type: COMPARATOR
Intervention: Placebo or usual care
Number of subjects: 0
Study 34791805 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg PEG rhG‐CSF
Number of subjects: 0
Study 34791805 — intervention group
Group type: COMPARATOR
Intervention: Control group (5 μg/kg rhG‐CSF administered when ANC reached grade 3)
Number of subjects: 0
Study 32098573 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoropyrimidine-based neoadjuvant chemotherapy (NACT) administered to 45 patients for a median of 8 weeks prior to surgical resection.
Number of subjects: 92
Study 32098573 — intervention group
Group type: COMPARATOR
Intervention: NACT group (short interval)
Number of subjects: 92
Study 32098573 — intervention group
Group type: COMPARATOR
Intervention: Long-interval and no NACT groups
Number of subjects: 92
Study 33560775 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE) (25 min at 45% PPEAK)
Number of subjects: 10
Study 33560775 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE) (8 × 60 s at 70% PPEAK)
Number of subjects: 10
Study 33560775 — intervention group
Group type: COMPARATOR
Intervention: No-Exercise Control (REST)
Number of subjects: 10
Study 32639470 — intervention group
Group type: EXPERIMENTAL
Intervention: PICU Supports
Number of subjects: 382
Study 32639470 — intervention group
Group type: COMPARATOR
Intervention: Brochure
Number of subjects: 382
Study 35667770 — intervention group
Group type: EXPERIMENTAL
Intervention: 110% high frequency (HF) rTMS
Number of subjects: 38
Study 35667770 — intervention group
Group type: COMPARATOR
Intervention: 70% low frequency (LF) rTMS
Number of subjects: 38
Study 33234156 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative viscosity
Number of subjects: 0
Study 33234156 — intervention group
Group type: COMPARATOR
Intervention: Positive viscosity
Number of subjects: 0
Study 33234156 — intervention group
Group type: COMPARATOR
Intervention: Breakthrough force
Number of subjects: 0
Study 34426738 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cathodal tDCS of the primary motor cortex of the unaffected hemisphere (ctDCSM1UH)
Number of subjects: 30
Study 34426738 — intervention group
Group type: COMPARATOR
Intervention: Sham ctDCS
Number of subjects: 30
Study 33940235 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg kg−1 of low dose rocuronium
Number of subjects: 100
Study 33940235 — intervention group
Group type: COMPARATOR
Intervention: No-NMBA (control)
Number of subjects: 100
Study 33940235 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 33374218 — intervention group
Group type: EXPERIMENTAL
Intervention: Octanoate-rich MCTs (C8R)
Number of subjects: 3
Study 33374218 — intervention group
Group type: EXPERIMENTAL
Intervention: Decanoate-rich MCTs (C10R)
Number of subjects: 3
Study 33374218 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (C8R and C10R)
Number of subjects: 3
Study 33374218 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate (control)
Number of subjects: 3
Study 32384953 — intervention group
Group type: EXPERIMENTAL
Intervention: nAg‐NPs (≥0.5 g/mL)
Number of subjects: 88
Study 32384953 — intervention group
Group type: EXPERIMENTAL
Intervention: nAg‐NPs (0.05 g/mL)
Number of subjects: 88
Study 32384953 — intervention group
Group type: EXPERIMENTAL
Intervention: nAg‐NPs (5 g/mL)
Number of subjects: 88
Study 32384953 — intervention group
Group type: EXPERIMENTAL
Intervention: nAg‐NPs
Number of subjects: 88
Study 32384953 — intervention group
Group type: COMPARATOR
Intervention: Nursing management modes
Number of subjects: 88
Study 35322167 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric exercises
Number of subjects: 24
Study 35322167 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration exercises
Number of subjects: 24
Study 32979978 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (titrated to a maximum dose of 2700 mg daily)
Number of subjects: 306
Study 32979978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306
Study 35697547 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative lidocaine infusion (continuous infusion of 2 mg kg‐1 h‐1 after 1.5 mg kg‐1 bolus at induction of anaesthesia)
Number of subjects: 563
Study 35697547 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 563
Study 34215238 — intervention group
Group type: EXPERIMENTAL
Intervention: Peking University First Hospital Score (PUFHS)
Number of subjects: 272
Study 34215238 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 272
Study 33225651 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse breech extraction (Group A)
Number of subjects: 110
Study 33225651 — intervention group
Group type: COMPARATOR
Intervention: Hand push method (Group B)
Number of subjects: 110
Study 36473006 — intervention group
Group type: EXPERIMENTAL
Intervention: MyPinkMom intervention program (six infographic video clips)
Number of subjects: 120
Study 36473006 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine counseling on anemia in pregnancy)
Number of subjects: 120
Study 32795589 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylation of MSI2
Number of subjects: 291
Study 32795589 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentially methylated positions (DMPs) associated with atopy
Number of subjects: 291
Study 32795589 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in MSI2 expression and methylation
Number of subjects: 291
Study 32795589 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentially methylated positions (DMPs) associated with tissue eosinophilia
Number of subjects: 291
Study 32385495 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment (not specified)
Number of subjects: 0
Study 32385495 — intervention group
Group type: COMPARATOR
Intervention: Active reference treatment (not specified)
Number of subjects: 0
Study 32385495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34972076 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-LED/loupe device
Number of subjects: 26
Study 34972076 — intervention group
Group type: COMPARATOR
Intervention: BLUE400 system
Number of subjects: 26
Study 34972076 — intervention group
Group type: COMPARATOR
Intervention: Comparison of triple-LED/loupe device to BLUE400
Number of subjects: 26
Study 33932179 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergic rhinitis patients (case group)
Number of subjects: 250
Study 33932179 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients without allergic rhinitis)
Number of subjects: 250
Study 32917288 — intervention group
Group type: EXPERIMENTAL
Intervention: Mistletoe extract (0.01 to 20 mg subcutaneously three times per week for 9 months)
Number of subjects: 290
Study 32917288 — intervention group
Group type: COMPARATOR
Intervention: Placebo (subcutaneously)
Number of subjects: 290
Study 32444433 — intervention group
Group type: EXPERIMENTAL
Intervention: InSpace balloon (Stryker, USA) with arthroscopic debridement
Number of subjects: 221
Study 32444433 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic debridement alone
Number of subjects: 221
Study 33914664 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR20
Number of subjects: 10
Study 33914664 — intervention group
Group type: COMPARATOR
Intervention: FF70
Number of subjects: 10
Study 33914664 — intervention group
Group type: EXPERIMENTAL
Intervention: FF20
Number of subjects: 10
Study 33914664 — intervention group
Group type: COMPARATOR
Intervention: FF20WM
Number of subjects: 10
Study 33914664 — intervention group
Group type: EXPERIMENTAL
Intervention: All protocols
Number of subjects: 10
Study 33109233 — intervention group
Group type: EXPERIMENTAL
Intervention: Neo-adjuvant lapatinib, trastuzumab, or their combination plus paclitaxel
Number of subjects: 454
Study 36047598 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg intravenous ferric carboxymaltose
Number of subjects: 278
Study 36047598 — intervention group
Group type: COMPARATOR
Intervention: 1000 mg intravenous ferric carboxymaltose
Number of subjects: 278
Study 33762190 — intervention group
Group type: EXPERIMENTAL
Intervention: MgSO4 50mgkg‐1 for 15 minutes followed by 15 mgkg‐1h‐1 until the end of the surgery
Number of subjects: 86
Study 33762190 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 86
Study 33762190 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups received 100μg of ITM
Number of subjects: 86
Study 33762190 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups received dipyrone+ketoprofen intraoperatively and postoperatively, and dexamethasone intraoperatively only
Number of subjects: 86
Study 32334548 — intervention group
Group type: EXPERIMENTAL
Intervention: mDCF plus atezolizumab (800 mg every 2 weeks)
Number of subjects: 99
Study 32334548 — intervention group
Group type: COMPARATOR
Intervention: mDCF
Number of subjects: 99
Study 35620476 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) delivered at Zusanli (ST36) and Neiguan (PC6) acupoints 24 hours before surgery.
Number of subjects: 80
Study 35620476 — intervention group
Group type: COMPARATOR
Intervention: Sham Electroacupuncture (SEA) group.
Number of subjects: 80
Study 35620476 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) group.
Number of subjects: 80
Study 33129363 — intervention group
Group type: EXPERIMENTAL
Intervention: Favipiravir and Hydroxychloroquine combination
Number of subjects: 472
Study 33129363 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 472
Study 35751913 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-session socio-behavioral health intervention utilizing sociodrama
Number of subjects: 0
Study 35751913 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34063191 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain rye bread (WGR)
Number of subjects: 9
Study 34063191 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain wheat bread (WGW)
Number of subjects: 9
Study 34063191 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat bread (WW)
Number of subjects: 9
Study 34610151 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive Er:YAG laser (ERL) in non-surgical periodontal therapy (NSPT)
Number of subjects: 22
Study 34610151 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment in non-surgical periodontal therapy (NSPT)
Number of subjects: 22
Study 33752127 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 0
Study 33752127 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 35587078 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser biostimulation (LB) and low-calorie diet (LCD)
Number of subjects: 66
Study 35587078 — intervention group
Group type: COMPARATOR
Intervention: Low-calorie diet (LCD) alone
Number of subjects: 66
Study 33352004 — intervention group
Group type: EXPERIMENTAL
Intervention: Washing without water method
Number of subjects: 97
Study 33352004 — intervention group
Group type: COMPARATOR
Intervention: Water and soap method
Number of subjects: 97
Study 33496530 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet enriched with extra-virgin olive oil or nuts
Number of subjects: 2188
Study 33496530 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet enriched with extra-virgin olive oil
Number of subjects: 2188
Study 33496530 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive therapy at baseline
Number of subjects: 2188
Study 35303516 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) enriched meal
Number of subjects: 32
Study 35303516 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat (FAT) enriched meal
Number of subjects: 32
Study 35303516 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein (PRO) enriched meal
Number of subjects: 32
Study 35303516 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 32
Study 34836152 — intervention group
Group type: EXPERIMENTAL
Intervention: Common Bean Baked Snack (CBBS) consumption (32 g for four weeks)
Number of subjects: 20
Study 34836152 — intervention group
Group type: COMPARATOR
Intervention: Control (no CBBS consumption)
Number of subjects: 20
Study 32033718 — intervention group
Group type: EXPERIMENTAL
Intervention: 17β‐E2
Number of subjects: 0
Study 32033718 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 0
Study 32033718 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA)
Number of subjects: 0
Study 32033718 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant
Number of subjects: 0
Study 32033718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0